Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. A. Ruefli

The Histone Deacetylase Inhibitor and Chemotherapeutic Agent Suberoylanilide Hydroxamic Acid (SAHA) Induces a Cell-Death Pathway Characterized by Cleavage of Bid and Production of Reactive Oxygen Species

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2001

English

Related publications

Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network

Molecular and Cellular Proteomics

English

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava

Frontiers in Plant Science

Plant Science

2017

English

Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells

Scientific Reports

Multidisciplinary

2016

English

The Proteasome Inhibitor Bortezomib Interacts Synergistically With the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid to Induce T-Leukemia/Lymphoma Cells Apoptosis

English

Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer in Vitro and in Vivo

PLoS ONE

Multidisciplinary

2013

English

The Role of Oxidative Stress in Apoptosis Induced by the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Human Colon Adenocarcinoma HT-29 Cells

International Journal of Oncology

Cancer Research

Oncology

1992

English

Histone Deacetylase Inhibitor SAHA Suppresses Human Adenovirus Gene Expression and Replication

English

Suberoylanilide Hydroxamic Acid (SAHA) Changes microRNA Expression Profiles in A549 Human Non-Small Cell Lung Cancer Cells

International Journal of Molecular Medicine

Medicine

Genetics

2009

English

Suberoylanilide Hydroxamic Acid (SAHA) Enhances Olaparib Activity by Targeting Homologous Recombination DNA Repair in Ovarian Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. A. Ruefli

The Histone Deacetylase Inhibitor and Chemotherapeutic Agent Suberoylanilide Hydroxamic Acid (SAHA) Induces a Cell-Death Pathway Characterized by Cleavage of Bid and Production of Reactive Oxygen Species

Related publications

Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava

Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells

The Proteasome Inhibitor Bortezomib Interacts Synergistically With the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid to Induce T-Leukemia/Lymphoma Cells Apoptosis

Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer in Vitro and in Vivo

The Role of Oxidative Stress in Apoptosis Induced by the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Human Colon Adenocarcinoma HT-29 Cells

Histone Deacetylase Inhibitor SAHA Suppresses Human Adenovirus Gene Expression and Replication

Suberoylanilide Hydroxamic Acid (SAHA) Changes microRNA Expression Profiles in A549 Human Non-Small Cell Lung Cancer Cells

Suberoylanilide Hydroxamic Acid (SAHA) Enhances Olaparib Activity by Targeting Homologous Recombination DNA Repair in Ovarian Cancer